Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation: current controversies.

E J Kanfer1

  • 1Department of Haematology, Charing Cross and Westminster Medical School, London, UK.

Bone Marrow Transplantation
|September 1, 1988
PubMed
Summary

Bone marrow transplantation (BMT) is a vital therapy for leukaemias, aplastic anaemia, and inherited diseases. This 1988 symposium reviewed BMT

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma.

Bone marrow transplantation·2016
Same author

LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.

Bone marrow transplantation·2006
Same author

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia.

British journal of cancer·2005
Same author

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

British journal of cancer·2004
Same author

Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells.

Current opinion in hematology·2000
Same author

CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome.

British journal of haematology·1999

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Oncology

Background:

  • The 1988 UCLA symposium convened experts to discuss bone marrow transplantation (BMT).
  • BMT was recognized as a significant therapeutic modality across various conditions.
  • The symposium aimed to consolidate current knowledge and future directions in BMT.

Purpose of the Study:

  • To provide a comprehensive overview of bone marrow transplantation (BMT) applications.
  • To evaluate the role and timing of BMT in treating acute and chronic leukaemias.
  • To discuss advancements in autologous grafting, aplastic anaemia, immune/metabolic diseases, and post-transplant complications.

Main Methods:

  • Review of current therapeutic strategies and clinical outcomes in BMT.
  • Discussion of challenges and advancements in transplantation procedures.
  • Presentation of data on BMT for various hematological and non-hematological conditions.

Main Results:

  • BMT demonstrated efficacy in treating leukaemias, aplastic anaemia, and inherited disorders.
  • Autologous grafting showed promise for hematological and non-hematological malignancies.
  • Key post-transplant complications like pneumonitis and graft-versus-host disease were extensively reviewed.

Conclusions:

  • Bone marrow transplantation (BMT) is a critical treatment for diverse diseases.
  • Further research and clinical application of BMT are warranted.
  • Management of complications and donor selection remain crucial for successful BMT outcomes.

Related Experiment Videos